Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen

Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen

US Patent 11325962 · Granted May 10, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-mucin 1 binding agents and uses thereof2019
Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC2016
Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC2016
Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC2016
Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC2016
Polypeptides derived from cyclin B1 and uses thereof2014
Anticancer vaccine and diagnostic methods and reagents2012
Anticancer vaccine and diagnostic methods and reagents2010
Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC2010
Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC2010
Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC2010
Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC2010